Nicholas E. Adamson
Managing Associate
Overview
Nick’s practice focuses on transactional and regulatory healthcare matters, including advising on Anti-Kickback and Stark issues, transactional drafting, diligence review and licensing. Additionally, Nick has experience guiding clients in the cannabis industry through complex issues such as corporate transactions, company formation, dispute handling, and compliance with state and federal regulations.
Nick also has experience as a judicial extern in the Eastern District of Michigan and a legal extern in the United States Attorney’s Office of Northeast Ohio, Civil Division. Prior to law school, Nick worked for several years as a paralegal at a large firm assisting primarily in MDL litigations and antitrust litigation.
Experience
Represented a regional dialysis provider in a $5 million joint-venture transaction with a national dialysis company. Advised the client on all stages of the deal, including structuring, regulatory review, negotiation of joint-venture and operating documents, and closing coordination. The engagement involved complex healthcare regulatory considerations, including joint-venture compliance, state facility-licensure strategy, and alignment with federal fraud and abuse frameworks.
Prepared various cannabis license renewal applications within the state of Illinois.
Represented provider practice in sale to larger management platform.
Represented nursing home portfolio in its $450 million dollar acquisition of nineteen skilled nursing facilities along with a pharmacy lab, nurse practitioner business, and independent living facility featuring a capital stack with five different lenders including mezzanine debt, assumption of existing HUD loans, and sale-leasebacks.
Advised cannabis company on state and county specific regulations concerning dispensary applications and licenses.
Assisted national cannabis-focused corporation in navigating 10-K annual report filings.
Represented physician group in an asset sale to a private equity backed management company.
Represented a cannabis software company in vendor dispute arbitration.
Represented a private equity-backed portfolio company in its acquisition of a Georgia-based Hospice.
No results found
Credentials
Education
- Operations Editor, Law Review
- President and Founding Member, Student Legislative Initiative of Cleveland (SLIC)
- Received numerous CALI Excellence for the Future Awards as distinction for highest grade
- Legal Writing Honor’s Fellow and tutor in Mergers and Acquisitions and Constitutional Law
- OSU Rugby team member
More
- Volunteer Children’s Hospital Magician with Open Heart Magic (OHM)
- Member, Chicago Bar Association
- Member, IL Bar Association
- Member, Cleveland Bar Association
Related News & Insights
The LEAD Model—Kidney Care’s Value-Based Care Journey LEADs Here
For more than a decade, nephrology practices have participated in Innovation Center kidney‑focused models—beginning with ESRD Seamless Care Organizations (“ESCOs”) under the Comprehensive ESRD Care (“CEC”) Model (2015–2021), followed by today’s Kidney Care Choices (“KCC”) Model (2022–2027). With KCC scheduled to end in December 2027, kidney care providers are approaching a critical transition point. The Long‑term Enhanced ACO Design (“LEAD”) Model, for which CMS released the Request for Applications (“RFA”) on March 31, 2026 (revised April 15, 2026), represents the next phase of CMS’s value‑based care strategy—but it differs fundamentally from the kidney‑specific models that preceded it.
LEAD vs. ACO REACH–What’s Changing and Why the LEAD Model Matters for ACOs and Participating Providers
The Long-term Enhanced ACO Design (“LEAD”) model is Centers for Medicare & Medicaid Services Innovation Center’s (Innovation Center) newly announced successor to the ACO Realizing Equity, Access, and Community Health (REACH) model. While LEAD retains the core framework of two-sided risk and population-based payments, it introduces critical changes aimed at making the program more sustainable, inclusive and effective to foster longer term administration for providers.
Nesko Radovic, Scott Downing, Jason Greis, Jake Cilek, Chris DeGrande and Nick Adamson Published in RPA News | “CMS Launches WISeR Model: A Technology-Enabled Effort to Reduce Wasteful Medicare Spending”
CMS’s CY 2026 Fee Schedule Proposal: MSSP Reforms Take Center Stage in Push Toward Value
On July 14, 2025, the Centers for Medicare & Medicaid Services (“CMS”) released the proposed rule for the Calendar Year …